Results from the TRIUMPH-1 trial, presented at the American Diabetes Association Scientific Sessions, show potential for retatrutide, an investigational GIP, GLP-1, and glucagon triple hormone receptor agonist, for treating obesity
Sometimes, your provider may simply need to adjust your GLP-1 dose or explore other options to better manage side effects
So many of my clients struggle not just with blood sugar instability, but with disrupted interoceptionblunted hunger/satiety cues, emotional eating, and poor nutrient sensing after years of stress, alcohol use, or ultra-processed food
This method provides more consistent absorption, allowing lower doses to produce stronger and more predictable effects
1) Why "Compounded" matters Most glutathione injectables are custom-mixed by compounding pharmacies